Dose distributions of optimized plans. حسب Hojin Kim (462672)

The flowchart showing the optimization process of the hybrid methods using BEOSA as the base algorithm and SA and FFA as integrated algorithms. حسب Olaide N. Oyelade (14047002)

الموضوعات:

Example medication days generated for patients P4 and P6, medication times (red dots), patient’s state—TRS score (blue line) with bounds for the states (red lines) and optimal stat... حسب Tomasz Gutowski (17200042)

Dose distribution comparisons. حسب Masashi Yagi (3186909)

الموضوعات:

Optimization parameters for the three treatment plans performed for the homogeneous and heterogeneous phantoms. حسب Masashi Yagi (3186909)

الموضوعات:

The <i>D</i>_<i>98</i> in the CTV and the for the nominal scenario optimized using the WC algorithm in homogeneous and heterogeneous phantom. حسب Masashi Yagi (3186909)

الموضوعات:

The <i>D</i>_<i>98</i> in the CTV and the for the nominal scenario optimized using the SC algorithm in homogeneous and heterogeneous phantoms. حسب Masashi Yagi (3186909)

الموضوعات:

An optimization process of the proposed hybrid BEOSA (HBEOSA) combining both SA and FFA methods into BEOSA. حسب Olaide N. Oyelade (14047002)

الموضوعات:

Fig 15 - حسب Masashi Yagi (3186909)

الموضوعات:

Fig 7 - حسب Masashi Yagi (3186909)

الموضوعات:

The SF of HSGc-C5 cells comparison among the experiment irradiated by IMCT (blue bar), the independent calculation (orange bar), and the experiment irradiated by SFUD (gray bar). حسب Masashi Yagi (3186909)

الموضوعات:

Fig 8 - حسب Masashi Yagi (3186909)

الموضوعات:

The heterogeneous phantom. حسب Masashi Yagi (3186909)

الموضوعات:

Fig 11 - حسب Masashi Yagi (3186909)

الموضوعات:

Treatment plan for the biological study. حسب Masashi Yagi (3186909)

الموضوعات:

Fig 9 - حسب Masashi Yagi (3186909)

الموضوعات:

Fig 6 - حسب Masashi Yagi (3186909)

الموضوعات:

Fig 10 - حسب Masashi Yagi (3186909)

الموضوعات:

Fig 12 - حسب Masashi Yagi (3186909)

الموضوعات:

Fig 5 - حسب Masashi Yagi (3186909)

الموضوعات: